N-[2-(3-tert-butylcyclobutyl)-6-chloroindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-(3-tert-butylcyclobutyl)-6-methoxyindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-[1-(2,2-dimethylpropanoyl)azetidin-3-yl]-6-methoxyindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-[1-(2-hydroxy-2-methylpropyl)azetidin-3-yl]-6-methoxyindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-[3-(2-hydroxypropan-2-yl)cyclobutyl]-6-methoxyindazol-5-yl]pyrazolo[1,5-a]pyrimidine-3-carboxamide;N-[2-[3-(2-hydroxypropan-2-yl)cyclobutyl]-6-methoxyindazol-5-yl]-3-(trifluoromethyl)benzamide

C135H143ClF15N27O15 — CID 165105178

IUPACN-[2-(3-tert-butylcyclobutyl)-6-chloroindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-(3-tert-butylcyclobutyl)-6-methoxyindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-[1-(2,2-dimethylpropanoyl)azetidin-3-yl]-6-methoxyindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-[1-(2-hydroxy-2-methylpropyl)azetidin-3-yl]-6-methoxyindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-[3-(2-hydroxypropan-2-yl)cyclobutyl]-6-methoxyindazol-5-yl]pyrazolo[1,5-a]pyrimidine-3-carboxamide;N-[2-[3-(2-hydroxypropan-2-yl)cyclobutyl]-6-methoxyindazol-5-yl]-3-(trifluoromethyl)benzamide
SMILESCC(C)(C)C1CC(n2cc3cc(NC(=O)c4cccc(C(F)(F)F)n4)c(Cl)cc3n2)C1.COc1cc2nn(C3CC(C(C)(C)C)C3)cc2cc1NC(=O)c1cccc(C(F)(F)F)n1.COc1cc2nn(C3CC(C(C)(C)O)C3)cc2cc1NC(=O)c1cccc(C(F)(F)F)c1.COc1cc2nn(C3CC(C(C)(C)O)C3)cc2cc1NC(=O)c1cnn2cccnc12.COc1cc2nn(C3CN(C(=O)C(C)(C)C)C3)cc2cc1NC(=O)c1cccc(C(F)(F)F)n1.COc1cc2nn(C3CN(CC(C)(C)O)C3)cc2cc1NC(=O)c1cccc(C(F)(F)F)n1
InChIInChI=1S/C23H24F3N5O3.C23H25F3N4O2.C23H24F3N3O3.C22H22ClF3N4O.C22H24F3N5O3.C22H24N6O3/c1-22(2,3)21(33)30-11-14(12-30)31-10-13-8-17(18(34-4)9-16(13)29-31)28-20(32)15-6-5-7-19(27-15)23(24,25)26;1-22(2,3)14-9-15(10-14)30-12-13-8-18(19(32-4)11-17(13)29-30)28-21(31)16-6-5-7-20(27-16)23(24,25)26;1-22(2,31)16-9-17(10-16)29-12-14-8-19(20(32-3)11-18(14)28-29)27-21(30)13-5-4-6-15(7-13)23(24,25)26;1-21(2,3)13-8-14(9-13)30-11-12-7-18(15(23)10-17(12)29-30)28-20(31)16-5-4-6-19(27-16)22(24,25)26;1-21(2,32)12-29-10-14(11-29)30-9-13-7-17(18(33-3)8-16(13)28-30)27-20(31)15-5-4-6-19(26-15)22(23,24)25;1-22(2,30)14-8-15(9-14)28-12-13-7-18(19(31-3)10-17(13)26-28)25-21(29)16-11-24-27-6-4-5-23-20(16)27/h5-10,14H,11-12H2,1-4H3,(H,28,32);5-8,11-12,14-15H,9-10H2,1-4H3,(H,28,31);4-8,11-12,16-17,31H,9-10H2,1-3H3,(H,27,30);4-7,10-11,13-14H,8-9H2,1-3H3,(H,28,31);4-9,14,32H,10-12H2,1-3H3,(H,27,31);4-7,10-12,14-15,30H,8-9H2,1-3H3,(H,25,29)
InChIKeyYZSDMESELJYOHS-UHFFFAOYSA-N
MW2704.23 g/mol
LogP27.64
Rot. Bonds27

About N-[2-(3-tert-butylcyclobutyl)-6-chloroindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-(3-tert-butylcyclobutyl)-6-methoxyindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-[1-(2,2-dimethylpropanoyl)azetidin-3-yl]-6-methoxyindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-[1-(2-hydroxy-2-methylpropyl)azetidin-3-yl]-6-methoxyindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-[3-(2-hydroxypropan-2-yl)cyclobutyl]-6-methoxyindazol-5-yl]pyrazolo[1,5-a]pyrimidine-3-carboxamide;N-[2-[3-(2-hydroxypropan-2-yl)cyclobutyl]-6-methoxyindazol-5-yl]-3-(trifluoromethyl)benzamide

N-[2-(3-tert-butylcyclobutyl)-6-chloroindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-(3-tert-butylcyclobutyl)-6-methoxyindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-[1-(2,2-dimethylpropanoyl)azetidin-3-yl]-6-methoxyindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-[1-(2-hydroxy-2-methylpropyl)azetidin-3-yl]-6-methoxyindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-[3-(2-hydroxypropan-2-yl)cyclobutyl]-6-methoxyindazol-5-yl]pyrazolo[1,5-a]pyrimidine-3-carboxamide;N-[2-[3-(2-hydroxypropan-2-yl)cyclobutyl]-6-methoxyindazol-5-yl]-3-(trifluoromethyl)benzamide (PubChem CID 165105178) has the molecular formula C135H143ClF15N27O15 and a molecular weight of 2704.23 g/mol. Its IUPAC name is N-[2-(3-tert-butylcyclobutyl)-6-chloroindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-(3-tert-butylcyclobutyl)-6-methoxyindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-[1-(2,2-dimethylpropanoyl)azetidin-3-yl]-6-methoxyindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-[1-(2-hydroxy-2-methylpropyl)azetidin-3-yl]-6-methoxyindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-[3-(2-hydroxypropan-2-yl)cyclobutyl]-6-methoxyindazol-5-yl]pyrazolo[1,5-a]pyrimidine-3-carboxamide;N-[2-[3-(2-hydroxypropan-2-yl)cyclobutyl]-6-methoxyindazol-5-yl]-3-(trifluoromethyl)benzamide.

Molecular Properties

Compound NameN-[2-(3-tert-butylcyclobutyl)-6-chloroindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-(3-tert-butylcyclobutyl)-6-methoxyindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-[1-(2,2-dimethylpropanoyl)azetidin-3-yl]-6-methoxyindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-[1-(2-hydroxy-2-methylpropyl)azetidin-3-yl]-6-methoxyindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-[3-(2-hydroxypropan-2-yl)cyclobutyl]-6-methoxyindazol-5-yl]pyrazolo[1,5-a]pyrimidine-3-carboxamide;N-[2-[3-(2-hydroxypropan-2-yl)cyclobutyl]-6-methoxyindazol-5-yl]-3-(trifluoromethyl)benzamide
PubChem CID165105178
Molecular FormulaC135H143ClF15N27O15
Molecular Weight2704.23 g/mol
Exact Mass2702.07
IUPAC NameN-[2-(3-tert-butylcyclobutyl)-6-chloroindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-(3-tert-butylcyclobutyl)-6-methoxyindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-[1-(2,2-dimethylpropanoyl)azetidin-3-yl]-6-methoxyindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-[1-(2-hydroxy-2-methylpropyl)azetidin-3-yl]-6-methoxyindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-[3-(2-hydroxypropan-2-yl)cyclobutyl]-6-methoxyindazol-5-yl]pyrazolo[1,5-a]pyrimidine-3-carboxamide;N-[2-[3-(2-hydroxypropan-2-yl)cyclobutyl]-6-methoxyindazol-5-yl]-3-(trifluoromethyl)benzamide
SMILESCC(C)(C)C1CC(n2cc3cc(NC(=O)c4cccc(C(F)(F)F)n4)c(Cl)cc3n2)C1.COc1cc2nn(C3CC(C(C)(C)C)C3)cc2cc1NC(=O)c1cccc(C(F)(F)F)n1.COc1cc2nn(C3CC(C(C)(C)O)C3)cc2cc1NC(=O)c1cccc(C(F)(F)F)c1.COc1cc2nn(C3CC(C(C)(C)O)C3)cc2cc1NC(=O)c1cnn2cccnc12.COc1cc2nn(C3CN(C(=O)C(C)(C)C)C3)cc2cc1NC(=O)c1cccc(C(F)(F)F)n1.COc1cc2nn(C3CN(CC(C)(C)O)C3)cc2cc1NC(=O)c1cccc(C(F)(F)F)n1
InChIInChI=1S/C23H24F3N5O3.C23H25F3N4O2.C23H24F3N3O3.C22H22ClF3N4O.C22H24F3N5O3.C22H24N6O3/c1-22(2,3)21(33)30-11-14(12-30)31-10-13-8-17(18(34-4)9-16(13)29-31)28-20(32)15-6-5-7-19(27-15)23(24,25)26;1-22(2,3)14-9-15(10-14)30-12-13-8-18(19(32-4)11-17(13)29-30)28-21(31)16-6-5-7-20(27-16)23(24,25)26;1-22(2,31)16-9-17(10-16)29-12-14-8-19(20(32-3)11-18(14)28-29)27-21(30)13-5-4-6-15(7-13)23(24,25)26;1-21(2,3)13-8-14(9-13)30-11-12-7-18(15(23)10-17(12)29-30)28-20(31)16-5-4-6-19(27-16)22(24,25)26;1-21(2,32)12-29-10-14(11-29)30-9-13-7-17(18(33-3)8-16(13)28-30)27-20(31)15-5-4-6-19(26-15)22(23,24)25;1-22(2,30)14-8-15(9-14)28-12-13-7-18(19(31-3)10-17(13)26-28)25-21(29)16-11-24-27-6-4-5-23-20(16)27/h5-10,14H,11-12H2,1-4H3,(H,28,32);5-8,11-12,14-15H,9-10H2,1-4H3,(H,28,31);4-8,11-12,16-17,31H,9-10H2,1-3H3,(H,27,30);4-7,10-11,13-14H,8-9H2,1-3H3,(H,28,31);4-9,14,32H,10-12H2,1-3H3,(H,27,31);4-7,10-12,14-15,30H,8-9H2,1-3H3,(H,25,29)
InChIKeyYZSDMESELJYOHS-UHFFFAOYSA-N
XLogP27.64
TPSA493.66 Ų
H-Bond Donors9
H-Bond Acceptors35
Rotatable Bonds27
Heavy Atoms193
Complexity—

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002704.23
LogP ≤ 527.64
H-Bond Donors ≤ 59
H-Bond Acceptors ≤ 1035

Analyze N-[2-(3-tert-butylcyclobutyl)-6-chloroindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-(3-tert-butylcyclobutyl)-6-methoxyindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-[1-(2,2-dimethylpropanoyl)azetidin-3-yl]-6-methoxyindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-[1-(2-hydroxy-2-methylpropyl)azetidin-3-yl]-6-methoxyindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-[3-(2-hydroxypropan-2-yl)cyclobutyl]-6-methoxyindazol-5-yl]pyrazolo[1,5-a]pyrimidine-3-carboxamide;N-[2-[3-(2-hydroxypropan-2-yl)cyclobutyl]-6-methoxyindazol-5-yl]-3-(trifluoromethyl)benzamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

N-[2-(3-tert-butylcyclobutyl)-6-cyanoindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-(3-tert-butylcyclobutyl)-6-methoxyindazol-5-yl]-4-(trifluoromethyl)pyrimidine-2-carboxamide;N-[2-(4,4-dimethylcyclohexyl)-6-methoxyindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-(4-hydroxycyclohexyl)-6-methoxyindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-[3-(2-hydroxypropan-2-yl)cyclobutyl]-6-methoxyindazol-5-yl]-6-(trifluoromethyl)pyrazine-2-carboxamide;N-[6-methoxy-2-(3-methoxycyclobutyl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide
CID 164970645
N-[2-(3-tert-butylcyclobutyl)-6-chloroindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-(3-tert-butylcyclobutyl)-6-fluoroindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-[3-(2-hydroxypropan-2-yl)cyclobutyl]indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[6-(2-hydroxypropan-2-yl)-2-[3-(2-hydroxypropan-2-yl)cyclobutyl]indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;bis(methyl 3-[6-methoxy-5-[[6-(trifluoromethyl)pyridine-2-carbonyl]amino]indazol-2-yl]cyclobutane-1-carboxylate)
CID 165006590
N-[2-(3-tert-butylcyclobutyl)-6-(dimethylamino)indazol-5-yl]-6-fluoropyridine-2-carboxamide;N-[2-(3-tert-butylcyclobutyl)-6-(2-hydroxypropan-2-yl)indazol-5-yl]-6-cyanopyridine-2-carboxamide;N-[2-(3-tert-butylcyclobutyl)-6-methoxyindazol-5-yl]-6-(difluoromethyl)pyridine-2-carboxamide;N-[6-(dimethylamino)-2-[3-(2-hydroxypropan-2-yl)cyclobutyl]pyrazolo[3,4-b]pyridin-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;6-fluoro-N-[2-[3-(2-hydroxypropan-2-yl)cyclobutyl]-6-methoxyindazol-5-yl]pyridine-2-carboxamide;N-[2-(3-hydroxy-3-methylcyclobutyl)-6-methoxyindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide
CID 165013662
N-[2-(3-tert-butylcyclobutyl)-6-(2-hydroxypropan-2-yl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-(3-tert-butylcyclobutyl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-(3-tert-butylcyclobutyl)-6-methoxyindazol-5-yl]-6-(difluoromethyl)pyridine-2-carboxamide;6-cyano-N-[6-(2-hydroxypropan-2-yl)-2-[3-(2-hydroxypropan-2-yl)cyclobutyl]indazol-5-yl]pyridine-2-carboxamide;N-[6-(dimethylamino)-2-[3-(2-hydroxypropan-2-yl)cyclobutyl]pyrazolo[3,4-b]pyridin-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[6-fluoro-2-[3-(2-hydroxypropan-2-yl)cyclobutyl]indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide
CID 165036828
N-[2-(3-tert-butylcyclobutyl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-(3-tert-butylcyclobutyl)-6-methoxyindazol-5-yl]pyrazolo[1,5-a]pyrimidine-3-carboxamide;N-[2-(3-tert-butylcyclobutyl)-6-methoxyindazol-5-yl]-3-(trifluoromethyl)benzamide;N-[6-chloro-2-[3-(2-hydroxypropan-2-yl)cyclobutyl]indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-[3-(hydroxymethyl)cyclobutyl]-6-methoxyindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-[3-(2-hydroxypropan-2-yl)cyclobutyl]-6-methoxyindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide
CID 165047205
N-[2-(3-tert-butylcyclobutyl)-6-cyanoindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-(3-tert-butylcyclobutyl)-6-(dimethylamino)indazol-5-yl]-6-fluoropyridine-2-carboxamide;N-[2-(3-tert-butylcyclobutyl)-6-methoxyindazol-5-yl]-4-(trifluoromethyl)pyrimidine-2-carboxamide;6-fluoro-N-[2-[3-(2-hydroxypropan-2-yl)cyclobutyl]-6-methoxyindazol-5-yl]pyridine-2-carboxamide;N-[2-[3-(2-hydroxypropan-2-yl)cyclobutyl]-6-methoxyindazol-5-yl]-6-(trifluoromethyl)pyrazine-2-carboxamide;N-[6-methoxy-2-(3-methoxycyclobutyl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide
CID 165073577
N-[2-(3-tert-butylcyclobutyl)-6-methoxyindazol-5-yl]-2-(trifluoromethyl)pyridine-4-carboxamide;N-[2-(3-tert-butylcyclobutyl)-6-methoxyindazol-5-yl]-6-(trifluoromethyl)pyridine-3-carboxamide;N-[6-chloro-2-[3-(2-hydroxypropan-2-yl)cyclobutyl]indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-[3-(2-hydroxypropan-2-yl)cyclobutyl]-6-methoxyindazol-5-yl]-4-(trifluoromethyl)pyridine-2-carboxamide;bis(methyl 3-[6-methoxy-5-[[6-(trifluoromethyl)pyridine-2-carbonyl]amino]indazol-2-yl]cyclobutane-1-carboxylate)
CID 165089910
1-[5-chloro-2-[3-methoxy-4-[methyl(2-pyrrolidin-1-ylethyl)amino]anilino]pyrimidin-4-yl]indole-3-carboxamide;1-[5-chloro-2-[3-methyl-4-[methyl(2-pyrrolidin-1-ylethyl)amino]anilino]pyrimidin-4-yl]indole-3-carboxamide;1-[2-(2-chloro-4-piperidin-1-ylanilino)pyrimidin-4-yl]-N-methylindole-3-carboxamide;1-[5-fluoro-2-[3-methoxy-4-[methyl(2-pyrrolidin-1-ylethyl)amino]anilino]pyrimidin-4-yl]indole-3-carboxamide;1-[2-[3-methoxy-4-[methyl(2-pyrrolidin-1-ylethyl)amino]anilino]-5-methylpyrimidin-4-yl]indole-3-carboxamide;N-methyl-1-[2-(4-piperidin-1-ylanilino)pyrimidin-4-yl]indole-3-carboxamide
CID 160460481

Frequently Asked Questions

What is the IUPAC name of N-[2-(3-tert-butylcyclobutyl)-6-chloroindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-(3-tert-butylcyclobutyl)-6-methoxyindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-[1-(2,2-dimethylpropanoyl)azetidin-3-yl]-6-methoxyindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-[1-(2-hydroxy-2-methylpropyl)azetidin-3-yl]-6-methoxyindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-[3-(2-hydroxypropan-2-yl)cyclobutyl]-6-methoxyindazol-5-yl]pyrazolo[1,5-a]pyrimidine-3-carboxamide;N-[2-[3-(2-hydroxypropan-2-yl)cyclobutyl]-6-methoxyindazol-5-yl]-3-(trifluoromethyl)benzamide?
The IUPAC name of N-[2-(3-tert-butylcyclobutyl)-6-chloroindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-(3-tert-butylcyclobutyl)-6-methoxyindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-[1-(2,2-dimethylpropanoyl)azetidin-3-yl]-6-methoxyindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-[1-(2-hydroxy-2-methylpropyl)azetidin-3-yl]-6-methoxyindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-[3-(2-hydroxypropan-2-yl)cyclobutyl]-6-methoxyindazol-5-yl]pyrazolo[1,5-a]pyrimidine-3-carboxamide;N-[2-[3-(2-hydroxypropan-2-yl)cyclobutyl]-6-methoxyindazol-5-yl]-3-(trifluoromethyl)benzamide (CID 165105178) is N-[2-(3-tert-butylcyclobutyl)-6-chloroindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-(3-tert-butylcyclobutyl)-6-methoxyindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-[1-(2,2-dimethylpropanoyl)azetidin-3-yl]-6-methoxyindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-[1-(2-hydroxy-2-methylpropyl)azetidin-3-yl]-6-methoxyindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-[3-(2-hydroxypropan-2-yl)cyclobutyl]-6-methoxyindazol-5-yl]pyrazolo[1,5-a]pyrimidine-3-carboxamide;N-[2-[3-(2-hydroxypropan-2-yl)cyclobutyl]-6-methoxyindazol-5-yl]-3-(trifluoromethyl)benzamide.
What is the SMILES notation for N-[2-(3-tert-butylcyclobutyl)-6-chloroindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-(3-tert-butylcyclobutyl)-6-methoxyindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-[1-(2,2-dimethylpropanoyl)azetidin-3-yl]-6-methoxyindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-[1-(2-hydroxy-2-methylpropyl)azetidin-3-yl]-6-methoxyindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-[3-(2-hydroxypropan-2-yl)cyclobutyl]-6-methoxyindazol-5-yl]pyrazolo[1,5-a]pyrimidine-3-carboxamide;N-[2-[3-(2-hydroxypropan-2-yl)cyclobutyl]-6-methoxyindazol-5-yl]-3-(trifluoromethyl)benzamide?
The canonical SMILES for N-[2-(3-tert-butylcyclobutyl)-6-chloroindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-(3-tert-butylcyclobutyl)-6-methoxyindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-[1-(2,2-dimethylpropanoyl)azetidin-3-yl]-6-methoxyindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-[1-(2-hydroxy-2-methylpropyl)azetidin-3-yl]-6-methoxyindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-[3-(2-hydroxypropan-2-yl)cyclobutyl]-6-methoxyindazol-5-yl]pyrazolo[1,5-a]pyrimidine-3-carboxamide;N-[2-[3-(2-hydroxypropan-2-yl)cyclobutyl]-6-methoxyindazol-5-yl]-3-(trifluoromethyl)benzamide is CC(C)(C)C1CC(n2cc3cc(NC(=O)c4cccc(C(F)(F)F)n4)c(Cl)cc3n2)C1.COc1cc2nn(C3CC(C(C)(C)C)C3)cc2cc1NC(=O)c1cccc(C(F)(F)F)n1.COc1cc2nn(C3CC(C(C)(C)O)C3)cc2cc1NC(=O)c1cccc(C(F)(F)F)c1.COc1cc2nn(C3CC(C(C)(C)O)C3)cc2cc1NC(=O)c1cnn2cccnc12.COc1cc2nn(C3CN(C(=O)C(C)(C)C)C3)cc2cc1NC(=O)c1cccc(C(F)(F)F)n1.COc1cc2nn(C3CN(CC(C)(C)O)C3)cc2cc1NC(=O)c1cccc(C(F)(F)F)n1.
What is the InChIKey of N-[2-(3-tert-butylcyclobutyl)-6-chloroindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-(3-tert-butylcyclobutyl)-6-methoxyindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-[1-(2,2-dimethylpropanoyl)azetidin-3-yl]-6-methoxyindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-[1-(2-hydroxy-2-methylpropyl)azetidin-3-yl]-6-methoxyindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-[3-(2-hydroxypropan-2-yl)cyclobutyl]-6-methoxyindazol-5-yl]pyrazolo[1,5-a]pyrimidine-3-carboxamide;N-[2-[3-(2-hydroxypropan-2-yl)cyclobutyl]-6-methoxyindazol-5-yl]-3-(trifluoromethyl)benzamide?
The InChIKey is YZSDMESELJYOHS-UHFFFAOYSA-N. The full InChI is InChI=1S/C23H24F3N5O3.C23H25F3N4O2.C23H24F3N3O3.C22H22ClF3N4O.C22H24F3N5O3.C22H24N6O3/c1-22(2,3)21(33)30-11-14(12-30)31-10-13-8-17(18(34-4)9-16(13)29-31)28-20(32)15-6-5-7-19(27-15)23(24,25)26;1-22(2,3)14-9-15(10-14)30-12-13-8-18(19(32-4)11-17(13)29-30)28-21(31)16-6-5-7-20(27-16)23(24,25)26;1-22(2,31)16-9-17(10-16)29-12-14-8-19(20(32-3)11-18(14)28-29)27-21(30)13-5-4-6-15(7-13)23(24,25)26;1-21(2,3)13-8-14(9-13)30-11-12-7-18(15(23)10-17(12)29-30)28-20(31)16-5-4-6-19(27-16)22(24,25)26;1-21(2,32)12-29-10-14(11-29)30-9-13-7-17(18(33-3)8-16(13)28-30)27-20(31)15-5-4-6-19(26-15)22(23,24)25;1-22(2,30)14-8-15(9-14)28-12-13-7-18(19(31-3)10-17(13)26-28)25-21(29)16-11-24-27-6-4-5-23-20(16)27/h5-10,14H,11-12H2,1-4H3,(H,28,32);5-8,11-12,14-15H,9-10H2,1-4H3,(H,28,31);4-8,11-12,16-17,31H,9-10H2,1-3H3,(H,27,30);4-7,10-11,13-14H,8-9H2,1-3H3,(H,28,31);4-9,14,32H,10-12H2,1-3H3,(H,27,31);4-7,10-12,14-15,30H,8-9H2,1-3H3,(H,25,29).
What are the key properties of N-[2-(3-tert-butylcyclobutyl)-6-chloroindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-(3-tert-butylcyclobutyl)-6-methoxyindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-[1-(2,2-dimethylpropanoyl)azetidin-3-yl]-6-methoxyindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-[1-(2-hydroxy-2-methylpropyl)azetidin-3-yl]-6-methoxyindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-[3-(2-hydroxypropan-2-yl)cyclobutyl]-6-methoxyindazol-5-yl]pyrazolo[1,5-a]pyrimidine-3-carboxamide;N-[2-[3-(2-hydroxypropan-2-yl)cyclobutyl]-6-methoxyindazol-5-yl]-3-(trifluoromethyl)benzamide?
N-[2-(3-tert-butylcyclobutyl)-6-chloroindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-(3-tert-butylcyclobutyl)-6-methoxyindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-[1-(2,2-dimethylpropanoyl)azetidin-3-yl]-6-methoxyindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-[1-(2-hydroxy-2-methylpropyl)azetidin-3-yl]-6-methoxyindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-[3-(2-hydroxypropan-2-yl)cyclobutyl]-6-methoxyindazol-5-yl]pyrazolo[1,5-a]pyrimidine-3-carboxamide;N-[2-[3-(2-hydroxypropan-2-yl)cyclobutyl]-6-methoxyindazol-5-yl]-3-(trifluoromethyl)benzamide has a molecular weight of 2704.23 g/mol, XLogP of 27.64, 27 rotatable bonds, 9 hydrogen bond donors, and 35 hydrogen bond acceptors.
Where does this data come from?
All data for N-[2-(3-tert-butylcyclobutyl)-6-chloroindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-(3-tert-butylcyclobutyl)-6-methoxyindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-[1-(2,2-dimethylpropanoyl)azetidin-3-yl]-6-methoxyindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-[1-(2-hydroxy-2-methylpropyl)azetidin-3-yl]-6-methoxyindazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide;N-[2-[3-(2-hydroxypropan-2-yl)cyclobutyl]-6-methoxyindazol-5-yl]pyrazolo[1,5-a]pyrimidine-3-carboxamide;N-[2-[3-(2-hydroxypropan-2-yl)cyclobutyl]-6-methoxyindazol-5-yl]-3-(trifluoromethyl)benzamide is sourced from PubChem (CID 165105178), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).